NO161563C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo(1,5-a)pyridinderivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo(1,5-a)pyridinderivater.

Info

Publication number
NO161563C
NO161563C NO840968A NO840968A NO161563C NO 161563 C NO161563 C NO 161563C NO 840968 A NO840968 A NO 840968A NO 840968 A NO840968 A NO 840968A NO 161563 C NO161563 C NO 161563C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
pyridine derivatives
analogy procedure
active pyrazolo
Prior art date
Application number
NO840968A
Other languages
English (en)
Norwegian (no)
Other versions
NO161563B (no
NO840968L (no
Inventor
Tsutomu Irikura
Keigo Nishino
Yoshio Nagatsu
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of NO840968L publication Critical patent/NO840968L/no
Publication of NO161563B publication Critical patent/NO161563B/no
Publication of NO161563C publication Critical patent/NO161563C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO840968A 1983-03-14 1984-03-13 Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo(1,5-a)pyridinderivater. NO161563C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58041957A JPH0613515B2 (ja) 1983-03-14 1983-03-14 ピラゾロ〔１，５−ａ〕ピリジン誘導体及びそれを含有する治療剤

Publications (3)

Publication Number Publication Date
NO840968L NO840968L (no) 1984-09-17
NO161563B NO161563B (no) 1989-05-22
NO161563C true NO161563C (no) 1989-08-30

Family

ID=12622665

Family Applications (1)

Application Number Title Priority Date Filing Date
NO840968A NO161563C (no) 1983-03-14 1984-03-13 Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo(1,5-a)pyridinderivater.

Country Status (10)

Country Link
US (1) US4654349A (es)
EP (1) EP0121806B1 (es)
JP (1) JPH0613515B2 (es)
KR (1) KR910001134B1 (es)
CA (1) CA1244435A (es)
DE (1) DE3478437D1 (es)
DK (1) DK164787C (es)
ES (4) ES530573A0 (es)
HU (1) HU191250B (es)
NO (1) NO161563C (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61186368A (ja) * 1985-02-14 1986-08-20 Kyorin Pharmaceut Co Ltd 新規な抗アレルギ−薬およびその製造方法
US4761403A (en) * 1986-04-09 1988-08-02 Abbott Laboratories Lipoxygenase inhibiting compounds
US4871745A (en) * 1986-09-22 1989-10-03 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents
US4963541A (en) * 1989-02-22 1990-10-16 Abbott Laboratories Pyrimido-pyrimidine lipoxygenase inhibiting compounds
JPH081997B2 (ja) * 1993-03-03 1996-01-10 日本電気株式会社 高周波モジュール実装構造
US6011052A (en) * 1996-04-30 2000-01-04 Warner-Lambert Company Pyrazolone derivatives as MCP-1 antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4821117B1 (es) * 1970-09-25 1973-06-26

Also Published As

Publication number Publication date
DK136684A (da) 1984-09-15
US4654349A (en) 1987-03-31
DE3478437D1 (en) 1989-07-06
DK164787C (da) 1992-12-28
ES8602784A1 (es) 1985-12-01
NO161563B (no) 1989-05-22
ES552545A0 (es) 1987-05-01
KR910001134B1 (ko) 1991-02-25
ES552546A0 (es) 1987-05-01
ES8705438A1 (es) 1987-05-01
JPS59167589A (ja) 1984-09-21
KR840008151A (ko) 1984-12-13
DK164787B (da) 1992-08-17
DK136684D0 (da) 1984-02-29
ES530573A0 (es) 1985-12-01
NO840968L (no) 1984-09-17
EP0121806A1 (en) 1984-10-17
JPH0613515B2 (ja) 1994-02-23
EP0121806B1 (en) 1989-05-31
HU191250B (en) 1987-01-28
ES544772A0 (es) 1986-10-16
ES8705437A1 (es) 1987-05-01
ES8700257A1 (es) 1986-10-16
CA1244435A (en) 1988-11-08

Similar Documents

Publication Publication Date Title
NO161372C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater.
NO157781C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, nye imidazo(1,2-a)pyridiner.
NO159724C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazo(1,2-a)-pyraziner.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO853100L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazo-pyridiner.
NO157819C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo (1,2-a)-pyridin-2-yl-karbostyrilforbindelser.
NO161802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO161319C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme imidazo-(1,5-a)pyridin-derivater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO164415C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO160442C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolo (1,5-a)pyridinderivater.
NO161563C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo(1,5-a)pyridinderivater.
NO159276C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme imidazo(1,5-a)pyridiner.
NO165595C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5,6,7-tetrahydrotiazolo<5,4-c>pyridinderivater.
NO163896C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive spiro-(1,8)-nafthyridin-dioner.
NO155773C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-substituerte tetrahydropyrrolo (1,2-a) pyrimidinderivater.
NO158063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.